Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-06-021233
Filing Date
2006-03-31
Accepted
2006-03-31 15:32:40
Documents
4
Period of Report
2005-12-28

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO ANNUAL REPORT PURSUANT TO SECTION 13 AND 15(D) a06-7968_110ka.htm 10-K/A 457950
2 MATERIAL CONTRACTS a06-7968_1ex10d15.htm EX-10.15 19968
3 302 CERTIFICATION a06-7968_1ex31d1.htm EX-31.1 4391
4 302 CERTIFICATION a06-7968_1ex31d2.htm EX-31.2 3883
  Complete submission text file 0001104659-06-021233.txt   487753
Mailing Address 4840 PEARL EAST CIRCLE SUITE 300W BOULDER CO 80301
Business Address 4840 PEARL EAST CIRCLE SUITE 300W BOULDER CO 80301 303-516-8500
TAPESTRY PHARMACEUTICALS, INC (Filer) CIK: 0000891504 (see all company filings)

EIN.: 841187753 | State of Incorp.: DE | Fiscal Year End: 1229
Type: 10-K/A | Act: 34 | File No.: 000-24320 | Film No.: 06728575
SIC: 2833 Medicinal Chemicals & Botanical Products